Abbott Laboratories $ABT, a leading company in the medical equipment and diagnostics sector, has announced significant plans to expand its manufacturing operations in the United States. In light of the growing impact of tariffs on the industry, the company intends to invest $500 million in the modernization and development of two facilities located in Illinois and Texas. This decision reflects Abbott's commitment not only to adapt to new economic realities but also to maintain its leadership by supporting innovation and product quality.

Stocks of Abbott Laboratories and Reckitt Benckiser Group Plc experienced a sharp decline in the market following the announcement of a new court trial related to allegations that the companies concealed potential risks associated with their formulas for premature infants. This situation has raised significant concern and attention among investors.